LATEST
El mundo se congela y arde pero Milei avanza contra el plan globalista Middle East Crisis: Oil Surpasses US$100 as US Threatens Iran Zelensky Appoints New Military Chief After Week of Protests in Ukraine Chile's Climate Crisis: 13 Dead, State of Catastrophe as 'El Niño Godzilla' Wreaks Havoc Argentina's Land Law Stalled: Senate Postpones Vote on Foreign Ownership Reform Post-World Cup Agenda: Argentina Government Pushes Tax Amnesty, Transfers Highways, and Milei Travels to Brazil Patagonia Snowstorm: Routes Affected and Tools for Safe Travel on July 23, 2026 Red Alert for Extreme Cold: Patagonia Faces One of Its Most Frigid Weeks Ed Harris's Frustration on Dutton Ranch: Why He Wanted to Quit and His Future in the Series María Becerra Waves the Argentine Flag in Spain Amidst World Cup Backlash El mundo se congela y arde pero Milei avanza contra el plan globalista Middle East Crisis: Oil Surpasses US$100 as US Threatens Iran Zelensky Appoints New Military Chief After Week of Protests in Ukraine Chile's Climate Crisis: 13 Dead, State of Catastrophe as 'El Niño Godzilla' Wreaks Havoc Argentina's Land Law Stalled: Senate Postpones Vote on Foreign Ownership Reform Post-World Cup Agenda: Argentina Government Pushes Tax Amnesty, Transfers Highways, and Milei Travels to Brazil Patagonia Snowstorm: Routes Affected and Tools for Safe Travel on July 23, 2026 Red Alert for Extreme Cold: Patagonia Faces One of Its Most Frigid Weeks Ed Harris's Frustration on Dutton Ranch: Why He Wanted to Quit and His Future in the Series María Becerra Waves the Argentine Flag in Spain Amidst World Cup Backlash
Español English 中文 Português Français Italiano Deutsch العربية Русский اردو

diagnóstico temprano

NIH-Funded Study Revolutionizes Early Alzheimer's Diagnosis

A groundbreaking study funded by the US National Institutes of Health (NIH) reveals that common blood tests can detect Alzheimer's disease biomarkers in middle-aged individuals, decades before the first memory symptoms appear. This promising medical breakthrough could completely change the landscape of early treatment and prevention for millions globally.

Jujuy Surpasses 13,600 Rapid HIV Tests in 2026

The Argentine province of Jujuy continues advancing in early HIV detection strategies, having conducted over 13,600 rapid tests during the first half of 2026. This initiative coincides with Argentina's National HIV Testing Day, a date that raises awareness about the importance of early diagnosis to reduce the 49% of cases detected at late stages nationwide.

HIV Detection Barriers in Argentina: Four Years After the Comprehensive Law

Four years after Argentina passed its landmark Comprehensive HIV Law, significant obstacles remain for early diagnosis. Sexually transmitted infections continue rising, with syphilis hitting record numbers in 2025, revealing urgent gaps in prevention policies and healthcare access across the country.

World ALS Day: Early Diagnosis Can Transform Lives for Patients

On World ALS Day, specialists emphasize the crucial importance of recognizing early symptoms to access timely treatments. Argentina registers between 900 and 1,000 new cases annually, making awareness essential for improving quality of life.

Kidney Cancer: The Silent Tumor That Could Rise 50% in Argentina by 2050

On World Kidney Cancer Day, specialists warn that this disease is often detected casually because it shows no symptoms in its early stages. Projections indicate a significant increase in cases, with a greater impact on men. Understanding risk factors and warning signs can make a crucial difference between a cure and an advanced illness.

Kidney Cancer: The Silent Tumor Set to Rise 50% in Argentina Within 20 Years

On World Kidney Cancer Day, specialists warn about the projected surge in cases across Argentina, where it already ranks as the fifth most common cancer. With over 2,500 deaths annually, late diagnosis remains the deadliest enemy. Learn about risk factors, silent symptoms, and why early detection can save lives.

Día Mundial de la Esclerosis Múltiple: Argentina lidera prevalencia en Latinoamérica con 17.000 afectados

El 30 de mayo se conmemora el Día Mundial de la Esclerosis Múltiple, enfermedad neurológica crónica que afecta predominantemente a mujeres entre 20 y 40 años. En Argentina hay aproximadamente 17.000 pacientes, la mayor prevalencia de la región con 36 casos por cada 100.000 habitantes. Expertos enfatizan la importancia del diagnóstico temprano y los avances en tratamientos que permiten una mejor calidad de vida.

El Alzheimer empieza a los 40: el neurólogo que revoluciona cómo prevenir la demencia

El doctor Pascual Sánchez Juan, director científico de la Fundación CIEN en España, revela que el Alzheimer tarda 20 años en manifestarse y que el cerebro alcanza su máximo esplendor a los 27 años. Con dos nuevos medicamentos aprobados y revolucionarios análisis de sangre para diagnóstico temprano, el experto asegura que el 40% de los casos son prevenibles.

Enfermedad renal: claves del diagnóstico temprano y avances que salvan vidas

La enfermedad renal crónica afecta al 10-12% de los adultos en Argentina y se proyecta como una de las cinco primeras causas de muerte mundial para 2040. La diabetes y la hipertensión causan más del 60% de los casos, pero exámenes simples permiten detectarla a tiempo y frenar su progresión.

Tres avances científicos revolucionan la detección temprana del Alzheimer mediante análisis de sangre

Investigadores de tres continentes presentaron hallazgos que podrían transformar el diagnóstico de enfermedades neurodegenerativas. Un estudio latinoamericano validó biomarcadores con 95% de precisión, científicos japoneses desarrollaron aptámeros de ADN más económicos, y un equipo de California demostró que es posible predecir demencia hasta 25 años antes de los síntomas.

Nueva vacuna contra el cáncer de páncreas muestra resultados esperanzadores en ensayo clínico

Una innovadora vacuna que aprovecha el sistema inmunológico para combatir células cancerígenas con mutación KRAS logró que pacientes con cáncer de páncreas sobrevivieran un promedio de dos años y cinco meses. El 68% de los participantes desarrolló una fuerte respuesta inmunitaria, ofreciendo una nueva esperanza para uno de los cánceres más letales que existe.

Today's News
Alfredo's Column Alfredo S. Quiroga

Alfredo S. Quiroga